ArticleTherapeutic advances in medical oncology2022

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.

Tiago de Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.